These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18670432)

  • 1. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential.
    Lambert DG
    Nat Rev Drug Discov; 2008 Aug; 7(8):694-710. PubMed ID: 18670432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain.
    El Daibani A; Che T
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?
    Zeilhofer HU; Calò G
    J Pharmacol Exp Ther; 2003 Aug; 306(2):423-9. PubMed ID: 12721334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
    Donica CL; Awwad HO; Thakker DR; Standifer KM
    Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
    Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D
    CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recently patented and promising ORL-1 ligands: where have we been and where are we going?
    Largent-Milnes TM; Vanderah TW
    Expert Opin Ther Pat; 2010 Mar; 20(3):291-305. PubMed ID: 20180617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central N/OFQ-NOP Receptor System in Pain Modulation.
    Kiguchi N; Ding H; Ko MC
    Adv Pharmacol; 2016; 75():217-43. PubMed ID: 26920014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ receptor expression in clinical pain disorders and functional effects in cultured neurons.
    Anand P; Yiangou Y; Anand U; Mukerji G; Sinisi M; Fox M; McQuillan A; Quick T; Korchev YE; Hein P
    Pain; 2016 Sep; 157(9):1960-1969. PubMed ID: 27127846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation.
    Rekik K; Faria Da Silva R; Colom M; Pacifico S; Zaveri NT; Calo' G; Rampon C; Frances B; Mouledous L
    Neuropharmacology; 2017 Oct; 125():39-49. PubMed ID: 28705439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.
    Journigan VB; Polgar WE; Khroyan TV; Zaveri NT
    Bioorg Med Chem; 2014 Apr; 22(8):2508-16. PubMed ID: 24657054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
    Gavioli EC; de Medeiros IU; Monteiro MC; Calo G; Romão PR
    Vitam Horm; 2015; 97():241-66. PubMed ID: 25677775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
    Sinchak K; Romeo HE; Micevych PE
    J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endogenous nociceptin/orphanin FQ-NOP receptor system as a potential therapeutic target for intestinal disorders.
    Agostini S; Petrella C
    Neurogastroenterol Motil; 2014 Nov; 26(11):1519-26. PubMed ID: 25307525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.